drugset

drugset / Trial / NCT06466278

IcoSApent ethyL to Slow Down Aortic VAlve Stenosis proGrEssion

NCT06466278 ↗

Phase 2 Active not recruiting 110 enrolled Academic Medical Center - University of Amsterdam

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study invastigates the effect of icosapent ethyl in patients with aortic valve stenosis.

Timeline

Start: 2023-06-01
Primary completion: 2026-07-01
Completion: 2026-12-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	icosapent ethyl	Small molecule	—	—

Indications